Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 117 clinical trials
Cardiometabolic Effects of Rapid Glucose Excursion

The effects of rapid glucose excursions, induced by intravenous bolus application of glucose in healthy probands, on cardiometabolic and inflammatory parameters will be investigated

  • 0 views
  • 19 Feb, 2024
At-Risk for Type 1 Diabetes Extension Study

This study is an extension of the NIH-sponsored AT-Risk (TN-10) type 1 diabetes study (NCT 01030861). Teplizumab-treated and placebo-treated participants in the NIH trial who develop clinical type 1 diabetes after the conclusion of that trial, are eligible to enroll and receive teplizumab treatment within one year of diagnosis of …

diabetes
teplizumab
type 1 diabetes mellitus
  • 0 views
  • 19 Feb, 2024
Internet Intervention for Diabetes Distress.

This study is designed to investigate the potential effectiveness of an internet-delivered intervention for diabetes distress in patients with type 2 diabetes.

Accepts healthy volunteers
  • 0 views
  • 20 Jun, 2025
  • 19 locations
SGLT2 Inhibition in Older Obese Adults With Pre-diabetes

Inhibitors of the sodium-glucose co-transporter (SGLT2) are FDA-approved for the treatment of type 2 diabetes (T2DM). Their mechanism of action involves lowering of blood glucose concentration secondary to increased glucose excretion of glucose by the kidney.

cognitive assessment
sglt2
type 2 diabetes mellitus
glycosylated hemoglobin
hba1c
  • 0 views
  • 19 Feb, 2024
Scripps Digital Diabetes: Cloud-Based Continuous Glucose Monitoring (CB CGM)

Individuals with diabetes in the hospital often experience poor glycemic control, which places them at greater risk for infection, neurological and cardiac complications, mortality, longer lengths of stay, readmissions, and higher healthcare costs.

poor glycaemic control
hyperglycemia
cardiovascular complication
continuous glucose monitoring
hypoglycemic agents
  • 0 views
  • 19 Feb, 2024
Incidence of Diabetes and Metabolic Disorders After TIPS in Cirrhotic Patients

Based on our retrospective data, TIPS induces in 30% of cirrhotic patients metabolic disorders associated with diabetes or pre-diabetes. The main objective is to measure the cumulative incidence of diabetes and pre-diabetes 6 months after TIPS insertion.

  • 0 views
  • 19 Feb, 2024
UPENN Case Test Trial 2 (Do Not Make Any Changes)

UPENN Case Test Trial 2 (Do Not Make Any Changes)

  • 0 views
  • 02 May, 2025
  • 1 location
UPENN Case Test Trial 4 (Do Not Make Any Changes)

UPENN Case Test Trial 4 (Do Not Make Any Changes)

  • 0 views
  • 02 May, 2025
  • 1 location
UPENN Case Test Trial 5 (Do Not Make Any Changes)

UPENN Case Test Trial 5 (Do Not Make Any Changes)

  • 0 views
  • 12 Jun, 2025
UPENN Case Test Trial 12 (Do Not Make Any Changes)

UPENN Case Test Trial 12 (Do Not Make Any Changes)

  • 0 views
  • 02 May, 2025